Related Experiment Video
Updated: May 5, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
In-vitro activity of polyhexanide alone and in combination with antibiotics against Staphylococcus aureus
1Institut für Medizinische Mikrobiologie, Virologie und Krankenhaushygiene, Universität Rostock, Rostock, Germany.
Background:
The resistance of Staphylococcus aureus is increasing, not only to antibiotics but also to antiseptics.
Aim:
To investigate the activity of the antiseptic polyhexanide and several antibiotics against clinical isolates of meticillin-susceptible and meticillin-resistant Staphylococcus aureus (MSSA and MRSA, respectively). Polyhexanide was tested alone and in combination with oxacillin, penicillin G, ampicillin, cefazolin, cefuroxime, imipenem, gentamicin, erythromycin, doxycycline, levoflocaxin, linezolid and vancomycin.
Methods:
Fifty MSSA and 50 MRSA strains, including one vancomycin-intermediate (VISA) strain, were tested. All strains were typed by pulsed-field gel electrophoresis (PFGE) to exclude testing of clonal isolates. Minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) were determined using the serial broth microdilution technique according to DIN 58940. Combinations of polyhexanide and different antibiotics were investigated using the checkerboard technique.
Findings:
Polyhexanide MICs and MBCs in the range of 0.5-2mg/L were found for both MSSA and MRSA, and the VISA strain had MIC and MBC values of 2mg/L. All isolates were regarded as susceptible to polyhexanide, and no antagonism was observed between polyhexanide and the tested antibiotics. Synergism between polyhexanide and some bacteriostatic antibiotics (erythromycin, doxycycline and linezolid) was found for some strains.
Conclusions:
Polyhexanide appears to be suitable for the topical treatment of S. aureus alone and in combination with antibiotics.
Insights
Polyhexanide effectively treats Staphylococcus aureus, including resistant strains, both alone and with antibiotics. This study shows its suitability for topical applications against common bacterial infections.
Area of Science:
- Antimicrobial resistance
- Clinical microbiology
- Infectious diseases
Background:
- Increasing resistance of Staphylococcus aureus to both antibiotics and antiseptics poses a significant clinical challenge.
- The need for effective treatment options against meticillin-susceptible and meticillin-resistant Staphylococcus aureus (MSSA and MRSA) is critical.
Purpose of the Study:
- To evaluate the antimicrobial activity of the antiseptic polyhexanide against clinical isolates of MSSA and MRSA.
- To assess the efficacy of polyhexanide in combination with various antibiotics against these strains.
Main Methods:
- Testing of 50 MSSA and 50 MRSA strains, including one vancomycin-intermediate strain.
- Determination of Minimum Inhibitory Concentrations (MICs) and Minimum Bactericidal Concentrations (MBCs) using broth microdilution.
- Investigation of polyhexanide-antibiotic combinations using the checkerboard technique.
Main Results:
- Polyhexanide demonstrated consistent activity against both MSSA and MRSA, with MICs and MBCs in the range of 0.5-2 mg/L.
- All tested isolates were susceptible to polyhexanide, with no antagonistic effects observed when combined with antibiotics.
- Synergistic activity was noted between polyhexanide and certain bacteriostatic antibiotics (erythromycin, doxycycline, linezolid) in some strains.
Conclusions:
- Polyhexanide exhibits significant antimicrobial activity against Staphylococcus aureus, including resistant strains.
- The antiseptic is suitable for topical treatment of S. aureus infections, both as a monotherapy and in combination with antibiotics.
Related Concept Videos
Antimicrobial Effectiveness
Clinical Significance of Antibiotic Resistance
Hand hygiene
Hand washing...
Combined Effects of Drugs: Synergism
Such synergistic combinations...

